XenoPort Hits Supply Trouble For Drug Horizant – Manufacturing.net

by admin on April 12, 2013

XenoPort Hits Supply Trouble For Drug Horizant
Manufacturing.net
(AP) — Drug developer XenoPort Inc. said Friday that there's a shortage of its restless leg syndrome treatment Horizant. The company said it's received word from patients unable to fill their Horizant prescriptions. XenoPort hopes that a new stock of
XenoPort: Manufacturing Delays Caused Stockout of HorizantFox Business

all 4 news articles »

View full post on restless leg syndrome – Google News

Leave a Comment

Previous post:

Next post: